Agilon raises 2026 outlook to $5.8B revenue and $85M adjusted EBITDA as risk adjustment estimate increases to 3% (NYSE:AGL)
· seekingalpha.com
agilon health (AGL) Q2 2026 earnings call recap: raised full-year guidance, improving cost trends, risk adjustment, and AI priorities.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...